Last reviewed · How we verify

NCT03609281

Cesarean Scar Characteristics After Scheduled and Emergency Cesarean Deliveries

Completed Last updated 23 April 2019
What this trial tests

trial testing Ultrasound assessement of uterine scar in Cesarean Scar Niche in 900 participants. Completed in 31 March 2019.

Timeline
1 August 2018
Primary endpoint
31 March 2019
31 March 2019

Quick facts

Lead sponsorTanta University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment900
Start date1 August 2018
Primary completion31 March 2019
Estimated completion31 March 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

Adults 20 to 35, female only, with Cesarean Scar Niche or Cesarean Wound; Dehiscence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was designed to evaluate the scar characteristics following scheduled and emergency cesarean deliveries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cesarean Scar Niche

Currently open trials in the same condition.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03609281.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing